HSE miss opportunity to pilot HIV drug
It is claimed the HSE missed a chance to pilot a drug credited with significantly reducing HIV infections.
PrEP, when used with safe safe sex practises, can cut the risk by up to 86%.
It costs around €400 for a one month supply and will not be available through the HSE until at least next year.
The Times of Ireland reports the manufacturer had discussed running a trial with the health authority.
